The Pregnant Diabetic. Queenie G. Ngalob, MD, FPCP May 5, 2014
|
|
- Phebe Morris
- 5 years ago
- Views:
Transcription
1 The Pregnant Diabetic Queenie G. Ngalob, MD, FPCP May 5, 2014
2 Outline Classification of diabetes in pregnancy Effect of diabetes and pregnancy on Conceptus Mother Treatment recommendations for pregnant diabetics
3 Classification of DM in pregnancy Preexisting Pregnancy PreGestational Diabetes (Type 1 or Type 2) Gestational Diabetes Overt Diabetes IADPSG. Diabetes Care. 2010; 33(3):
4 Classification of DM in pregnancy Preexisting Pregnancy PreGestational Diabetes (Type 1 or Type 2) Gestational Diabetes Overt Diabetes UNITE for Diabetes (Philippines) Evaluate for risk factors on 1 st prenatal visit 75gm OGTT ASAP if with any risk factor, th week if none Unite for Diabetes.
5 Risk factors for GDM Prior GDM Glucosuria Family history of DM Prior macrosomic (>8lbs) baby Macrosomia in current pregnancy Age 25 years old PCOS Overweight or obese Polyhydramnios in current pregnancy Intake of drugs affecting carbohydrate metabolism Unite for Diabetes.
6 Diagnosis 1 st Prenatal Visit Diagnosis FBS, mg/dl (mmol/l) RBS, mg/dl (mmol/l) HBA1C* % Overt Diabetes** 126 ( 7.0) 200 ( 11.1) 6.5 Gestational Diabetes ( ) na na *NGSP certified & standardized to the DCCT reference assay ** repeated on another day If criteria not met, repeat testing at weeks AOG using 75gm OGTT ADA 2014,WHO 2013, EndoSoc 2013, IADPSG 2010
7 Diagnosis 24 th 75 gm OGTT Diagnosis FBS, mg/dl (mmol/l) to 28 th week AOG using 1 st hour mg/dl (mmol/l) 2 nd hour mg/dl (mmol/l) Overt Diabetes** 126 ( 7.0) na 200 ( 11.1) Gestational Diabetes ( ) 180 ( 10.0) ( ) ADA 2014,WHO 2013, EndoSoc 2013, IADPSG 2010
8 Classification of DM in pregnancy Preexisting Pregnancy PreGestational Diabetes (Type 1 or Type 2) Gestational Diabetes Overt Diabetes IADPSG. Diabetes Care. 2010; 33(3):
9 Effect DM on the conceptus Fetal malformation Spontaneous abortion Perinatal mortality
10 Fetal Malformations fold higher risk 3 rd to 7 th weeks AOG embryogenesis & organogenesis Toxic metabolites may be teratogenic Pathogenesis is poorly understood Rates similar between Type 1 & 2 Boulot P, et al., Diabetes Care 26: , 2003 Lapolla A., et al. Nutr Metab Cardiovasc Dis May;18(4):291-7 Persson M, et al., Diabetes Care Nov;32(11): Eriksson UJ, et al.,. Rev Endocrinol Metabol Dis 2003;4: Kousseff BG. Diabetic embryopathy. Curr Opin Pediatr 1999;11:348 Bell R., et al., BJOG Mar;115(4):
11 Congenital malformations The poorer the glycemic control periconceptionally or early in pregnancy, the greater the risk for congenital anomalies. Towner D, et al., Diabetes Care 1995;18: Langer O, et al., J Mat Fet Med 2000;9: Temple R, et al., BMJ 2002;325: Schaefer-Graf UM, et al., Am J Obstet Gynecol 2000;182: Suhonen L, et al., Diabetologia 2000;43:79 82.
12 Malformations associated with preexisting diabetes OR CNS All 1.55 anencephalus 1.9 Encephalocoele 3.27 Head Anotia 4.37 GI Omphalocoele 2.32 Urinary Bilateral Renal agenesis 2.43 Musculoskeletal All 1.66 Garne E, et al., Birth Defects Research (Part A) 94: , 2012
13 Malformations associated with preexisting diabetes Congenital heart defects OR All 2.07 Common arterial truncus 2.59 Transposition of great vessels 2.00 Single ventricle 2.57 Ventricular septal defect 1.43 Atrial septal defect 2.15 Atrioventricular septal defect 2.21 Coarctation of the Aorta 1.84 Garne E, et al., Birth Defects Research (Part A) 94: , 2012
14 Spontaneous abortions 4 fold increased risk Risk rises poor glycemic control Temple R., BMJ Nov 30;325(7375):
15 Perinatal mortality 2.3 to 6- fold increased risk Intrauterine stillbirth (>24 weeks AOG) or neonatal death (within 28 days of life) Feig, et al., Diabetes Care Apr 4. [Epub ahead of print] Boulot P, et al., Diabetes Care 26: , 2003 Dunne R, et al., Diabet Med Sep;20(9): Lapolla A., et al. Nutr Metab Cardiovasc Dis May;18(4):291-7 Persson M, et al., Diabetes Care Nov;32(11):2005-9
16 Pregnancy Loss Cundy T, et al., Diabetes Care 30: , 2007
17 Perinatal outcomes MACROSOMIA OR (95% CI ) PRETERM OR 4.86 (95% CI ) FETAL DISTRESS OR (95% CI ) RESPIRATORY DISTRESS SYNDROME OR 4.65 (95% CI ) Perrson M, et al., Diabetes Care 32: , 2009
18 Effect DM on the conceptus Pantalone K, et al., Endocr Pract. 2011;17:
19 Effect of pregnancy on the diabetic mother DM Complications Obstetric Outcomes
20 DM retinopathy No to mild retinopathy Small risk for progression Established retinopathy can rapidly progress during and up to 1 year after pregnancy, more so in poorly controlled (OR 1.63 to 2.48) Effects of pregnancy on retinopathy eventually diminish after the first year. DCCT group. Diabetes Care 23: , 2000 Boulot P, et al., Diabetes Care 26: , 2003 D. Thompson et al., Can J Diabetes 37 (2013) S168eS183 Chew EY, et al., Diabetes Care May;18(5):6
21 Patients with more severe diabetic retinopathy at baseline were more likely to show progression (Χ 2 trend P<0.001) Chew EY, et al., Diabetes Care May;18(5):631-7.
22 Patients with higher levels of HBA1C were at greater risk for progression Chew EY, et al., Diabetes Care May;18(5):631-7.
23 DM nephropathy Normal creatinine albuminuria and creatinine clearance is preserved during pregnancy Microalbuminuria may worsen but typically modest and reversible (BP and blood sugar are wellcontrolled) Moderate to severe can significantly deteriorate and may not be reversible Rossing K, et al., Diabetologica 2002, 45: Miodovnik M, et al., Am J Obstet Gynecol 1996;174: Biesenbach, et al., Nephrol. Dial. Transplant. (1992) 7 (2): Purdy LP, et al., Diabetes Care Oct;19(10):
24 DM nephropathy & pregnancy outcomes Increased risk of preeclampsia, exacerbation of hypertension (OR ) Hypertension leads to increased risk of preterm delivery Placental dysfunction leads to intrauterine growth restriction and fetal distress Sibai BM, et al., Am J Obstet Gynecol Feb;182(2):364-9 Jensen DM, et al., Diabetes Care 33:90 94, 2010 Ekbomm P, et al, Diabetes Care 24: , 2001
25 Obstetric Outcomes PREECLAMPSIA OR 4.47 (95% CI 3.77 to 5.31) CESAREAN SECTION OR 5.31 (95% CI 4.97 TO 5.69) VACUUM EXTRACTION/FORCEP S OR 1.41 (95% CI 1.25 TO 1.58) Perrson M, et al., Diabetes Care 32: , 2009
26 Management of PreGDM
27 Management of PreGDM Preconception During Pregnancy Postpartum Counseling Glycemic control Weight control Co-morbidities
28 Preconception Counseling Should be provided to all diabetic women of childbearing potential or considering pregnancy Start at puberty or on diagnosis Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 ADA, Diabetes Care Jan;37 Suppl 1:S14-80 IDF 2009.
29 Preconception Counseling Need for pregnancy to be planned, sufficient control of glucose & co-morbidities Risk of malformations & adverse outcomes associated with unplanned pregnancy or poor metabolic control Use of effective contraception Time, commitment and effort is required Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 ADA, Diabetes Care Jan;37 Suppl 1:S14-80 IDF 2009.
30 Preconception Counseling Diabetes Specialist Dietician Patient & partner Diabetes Educator Obstetrictian
31 Improved glycemic parameters Outcome Mean HBA1C decrease in the 1 st trimester No. of Studies Mean Difference (95% CI) % (-2.05, -1.79) Wahabi et al. BMC Public Health 2012, 12:792
32 Decreased risk for congenital malformations OR = 0.25 (0.16, 0.37) Wahabi et al. BMC Public Health 2012, 12:792
33 Decreased Perinatal Mortality OR = 0.34 (0.15, 0.75) Wahabi et al. BMC Public Health 2012, 12:792
34 Preconception Glycemic Control Strive to achieve blood glucose and HBA1C as close to normal as possible when they can be safely achieved without undue hypoglycemia. ideal preconception glucose levels not established Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
35 OR 1.3 (95% CI 1.2, 1.4) for every 1% increase in HBA1C Bell R, et al. Diabetologia Feb 8.
36 Strategies : Insulin-treated Intensified therapy using subcutaneous insulin Provide basal coverage Human insulin : NPH Analogs : Glargine, Detemir Provide prandial coverage Human insulin : regular Analogs : Aspart, Lispro Kitzmiller JL, et al., Diabetes Care May;31(5):
37 Jacobs DM Care 20:1279, 1997
38 Jacobs DM Care 20:1279, 1997
39 Strategies : Insulin-treated Recommend multiple daily doses of insulin or continuous SC insulin infusion over split-dose, premixed insulin Changes should be done well before conception or before withdrawing contraception to allow patient to gain expertise Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
40 Strategies : Insulin-treated Suggest rapid acting insulin analog (aspart or lispro) in preference to regular insulin Basal insulins detemir and glargine : preconceptionally & during pregnancy Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
41 Strategies : OHAS-treated No trials on use of oral hypoglycemics in pregestational DM Shift to insulin Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Kitzmiller JL, et al., Diabetes Care May;31(5):
42 Overweight & Obese Weight reduction before pregnancy for overweight and obese diabetic women. Increased risk for complications during pregnancy Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
43 OR for maternal outcomes according to antenatal BMI Overweight ( kg/m2) n=2882 Obese ( kg/m2) n=1679 Morbidly obese (>40 kg/m2) n-=248 Hypertensive disorders 1.74 ( ) 3.0 ( ) 4.87 ( ) Gestational Diabetes 1.78 ( ) 2.95 ( ) 7.44 ( ) Caesarean section 1.5 ( ) 2.02 ( ) 2.54 ( ) Callaway LK, et al., Med J Aust 2006; 184 (2):
44 Overweight ( kg/m2) n-=2882 Obese ( kg/m2) N=1679 Birth defects 1.58 ( ) Hypoglycemia 2.57 ( ) Prematurity (<34 wks) Admission to NICU OR for neonatal outcomes according to antenatal BMI Morbidly obese (>40 kg/m2) n-= ( ) 7.14 ( ) 2.13 ( ) 2.77 ( ) Callaway LK, et al., Med J Aust 2006; 184 (2):
45 Ocular care Have a detailed ocular assessment by a suitably-trained and qualified eye care professional in advance of withdrawing contraception or trying to conceive If retinopathy is documented, should be appraised of risk of worsening during pregnancy. Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
46 Ocular care If degree of retinopathy warrants therapy, recommend deferring conception until the retinopathy has been treated and stabilized. The greater the degree of preconception retinopathy, the greater the risk of progression during pregnancy Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Chew EY, et al., Diabetes Care May;18(5):631-7.
47 Patients in whom retinopathy was most likely to progress had both the poorest control at baseline and largest improvement during early pregnancy Chew EY, et al., Diabetes Care May;18(5):631-7.
48 Renal Function Have renal function assessed in advance of withdrawing contraception or trying to conceive Urine albumincreatinine ratio Serum Crea egfr Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
49 Renal Function If with significantly reduced GFR, refer to nephrologist before pregnancy baseline renal assessment review the woman s specific risk of worsening renal function in the event of pregnancy Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
50 Address Co-morbidities HYPERTENSION Satisfactory BP control (<130/80) preconception Withdraw ACEI and ARB DYSLIPIDEMIA Withdraw statins VASCULAR RISK Evaluate risk factors screening for CAD treat and counsel Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
51 Preconception During Pregnancy Postpartum Counselling Glycemic control Weight control Co-morbidities Targets SMBG MNT Weight management Pharmacologic Peripartum
52 Glycemic Targets Parameter Fasting & Preprandial Goal mg/dl (mmol/l) 95 ( 5.3) 90 (5.0) if can be achieved without hypoglycemia 1 hour PP 140 ( 7.8) 2 hour PP 120 ( 6.7) HBA1C 7 % (ideally 6.5) Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
53 Self-monitoring of blood glucose (SMBG) Recommend SMBG in all DM pregnant patients Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
54 Self-monitoring of blood glucose (SMBG) Recommend SMBG in all DM pregnant patients Frequency Fasting & Pre-meals Postprandial - 1 or 2 hours after the start of each meal, choosing when is peak bedtime and during the night as indicate. Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Negrato CA, et al., Diabetol Metab Syndr Dec 22;4(1):54.
55 HBA1C Perform HBA1C at the initial visit and monthly until target levels are achieved, then 2-3 months thereafter. Targets EndoSoc : 7% (6.5% ideal) ADA : <6% Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Kitzmiller JL, et al., Diabetes Care May;31(5):
56 Medical Nutrition Therapy (MNT) Recommend MNT to help achieve and maintain desired glycemic control while providing essential nutrient requirements Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Kitzmiller JL, et al., Diabetes Care May;31(5):
57 Medical Nutrition Therapy (MNT) a carbohydrate-controlled meal plan Promotes adequate nutrition and weight gain, normoglycemia and no ketosis Individualized, adjusted as pregnancy progresses CHO : 35-45% of TCR 3 small to moderate-sized meals 2 to 4 snacks Including evening snack Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
58 Weight Management Follow the Institute of Medicine revised guidelines for weight gain during pregnancy Excess weight gain associated with macrosomia (OR 3.58) Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Kitzmiller JL, et al., Diabetes Care May;31(5):
59 2009 Institute of Medicine Recommendations for total and rate of weight gain in pregnancy, by Prepregnancy BMI Prepregnancy BMI Range (kg) Rates of weight gain in 2 nd & 3 rd trimester Mean (Range), kg/wk Underweight (<18.5 kg/m 2 ) ( ) Normal ( kg/m 2 ) ( ) Overweight ( kg/m 2 ) ( ) Obese ( 30 kg/m 2 ) ( ) Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
60 Pharmacologic Therapy Provide background/ basal coverage Human insulin : NPH Analogs : Glargine, Detemir Provide prandial coverage Match with carbohydrate intake Human insulin : regular Analogs : Aspart, Lispro Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Kitzmiller JL, et al., Diabetes Care May;31(5):
61 Strategies Recommend multiple daily doses of insulin or continuous SC insulin infusion over split-dose, premixed insulin Suggest rapid acting insulin analog (aspart or lispro) in preference to regular insulin Suggest use of basal insulins for pregnancy: Detemir or glargine Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Kitzmiller JL, et al., Diabetes Care May;31(5):
62 Pharmacologic Therapy Suggest that Detemir be initiated in 1. Require basal insulin 2. NPH insulin, in appropriate doses, has previously resulted in, or thought that may result in problematic hypoglycemia 3. Successfully taking detemir before pregnancy. Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
63 Detemir in pregnancy P I O M 310 T1DM women planning to be or pregnant at 8-12 weeks AOG, A1C 8% on confirmation or pregnancy 17 countries Detemir vs NPH insulin Primary: HBA1C at 36 wks AOG Secondary: A1C at 8-12, 14 and 24 wks AOG, # attaining 6%, FPG, SMBG Maternal : hypoglycemia, deterioration of retinopathy, AE, weight gain Open-labelled, randomized trial, noninferiority Mathiesen ER, et al., Diabetes Care 35: , 2012
64 Results Glycemic outcomes Parameter at 36 weeks AOG Detemir (n=152) NPH (n=158) significance HBA1C 6.27% 6.33% (95% CI-0.21 to 0.08) HBA1C 6% 41% 32% P=0.28 Estimated mean FPG Mean PG from 8-point SMPG 85.7 mg/dl 97.4 mg/dl P=0.017* 119 mg/dl 123 mg/dl P=0.082 Mathiesen ER, et al., Diabetes Care 35: , 2012
65 Results Maternal tolerability Parameter at 36 weeks AOG Detemir (n=152) NPH (n=158) significance Major hypoglycemia 16% 21% P=0.615 Weight gain 11.5kg 11kg NS Adverse Events (AE) Reported as same ~90% Serious AE 40% 31% * To be Reported in another paper Mathiesen ER, et al., Diabetes Care 35: , 2012
66 Results Maternal tolerability Outcome Detemir n=152 NPH n=158 Serious Adverse Events 40 % 31 % Pregnancy, puerperium, perinatal conditions 25.7 % 16.5 % Few events were considered by the investigator to be possibly or probably related to one or both investigational products (between 8-12% of the mothers) Infection & infestation 4.6 % 1.3 % Reproductive system & breast 2.0 % 3.2 % Nervous system 2.6 % 1.3 % Metabolism and nutrition disorders 11.2 % 8.2 % Hypoglycemia unawareness 2 pts 7 pts Diabetes inadequate control 5 pts 1 pts DKA 3 pts 0 pts Mathiesen ER, et al., Diabetes Care 35: , 2012
67 Detemir in Pregnancy Perinatal and Obstetric Outcomes P I O M 310 T1DM women planning to be or pregnant at 8-12 weeks AOG, A1C 8% on confirmation or pregnancy 17 countries Detemir vs NPH insulin Composite pregnancy outcome GA Sample at delivery, size computed SGA or LGA, based birthweight, on primary macrosomia, live births, early fetal death, perinatal mortality and induced abortions, detect perinatal neonatal and hypoglycemia, obstetric congenital outcomes malformations, preterm delivery, preeclampsia, AE (fetal & Maternal outcome (HBA1C at 36 weeks) and NOT to Open-labelled, randomized trial, noninferiority Hod M, et al., J Matern Fetal Neonatal Med, 2014; 27(1): 7 13
68 Results perinatal & obstetric outcomes Parameter- Detemir (n=152) NPH (n=158) significance Composite outcome 62.7% 66.2% OR 0.86 (95% CI 0.53, 1.40) GA at delivery (wks) 38.2 (SD 1.9) 37.8 (SD 1.5) P=0.012 Live births 90.1% 93.8% P=0.284 Preterm delivery 20.3% 26.5% P=0.238 Early fetal death 7.7% 6.2% - Perinatal death Neonatal death SGA 2.3% 0.7% - LGA Macrosomia Neonatal hypoglyc Hod M, et al., J Matern Fetal Neonatal Med, 2014; 27(1): 7 13
69 Results Congenital Malformations based on treatment during organogenesis Parameter Detemir (n=84) NPH (n=154) Significance Congenital 4.8% 7.1% - malformation Minor malformation 1.2% 5.2% - Major malformation 3.6% 1.9% - Hod M, et al., J Matern Fetal Neonatal Med, 2014; 27(1): 7 13
70 Results Adverse Events in Children Parameter Detemir (n=84) NPH (n=154) significan ce AE 36.8% 34.8% - Serious AE Severe AE AE possibly/probably related to basal insulin Detemir is well-tolerated Further reassurance will be provided with the collection of longterm observational data from a large cohort. Hod M, et al., J Matern Fetal Neonatal Med, 2014; 27(1): 7 13
71 Glargine Suggest that pregnant women successfully using glargine before pregnancy may continue it during pregnancy Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
72 Glargine Increased affinity to IGF-1 receptors mitogenicity Role of IGF-1 in fetal tissues Placenta perfusion study showed that glargine does not cross the placenta Kurtzhals P, et al., Diabetes 2000; 49: Chisalta SI, et al., Am J Physiol Endocrinol Metab 286: E896 E901, Pollex E, et al., Diabetes Care 33:29 33, 2010
73 Glargine Maternal outcomes Outcome 1 st Trimester HBA1C Severe Hypoglycemia # of studi es Gl N I 2 Effect (OR) 95% CI NPH % (Mean Diff) , % , 3.79 Preeclampsia % , 1.32 Gestational/ New Onset HPN % , 1.2 Lepercq J, et al., Obstet Gynecol Int. 2012;2012:649070
74 Glargine Neonatal outcomes Outcome Neonatal hypoglycemia # of studie s Gl N I 2 Effect (OR) 95% CI NPH % , 1.56 NICU admission % , 1.38 Congenital malformations % , 1.59 Macrosomia % , 2.02 Lepercq J, et al., Obstet Gynecol Int. 2012;2012:649070
75 Glargine Current available data from retrospective studies and one prospective cohort show that glargine does not result in increased risk for the mother and fetus. Lepercq J, et al., Obstet Gynecol Int. 2012;2012:649070
76 Pharmacologic Therapy NO randomized clinical trials regarding the use of non-insulin antihyperglycemics in pregestational diabetes Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Kitzmiller JL, et al., Diabetes Care May;31(5):
77 Pharmacologic Therapy NO randomized clinical trials regarding the use of non-insulin antihyperglycemics in pregestational diabetes Shift OHAS to insulin once pregnancy confirmed Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Kitzmiller JL, et al., Diabetes Care May;31(5):
78 Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 ADA 2014 Standards of Care. Diab Care (37) : S14-80, 2014 Labor & Delivery Suggested targets during labor & delivery : mg/dl ( mmol/l)
79 Labor & Delivery Hyperglycemia during labor and delivery increases risk of neonatal hypoglycemia fetal distress birth asphyxia abnormal heart rate Method: No evidence on single best way of maintaining target BG No recommendation and at discretion of practitioner Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
80 Preconception During Pregnancy Postpartum Counselling Glycemic control Weight control Co-morbidities Targets SMBG MNT Weight management Pharmacologic Peripartum Lactation
81 Lactation Recommend whenever possible, women with diabetes should breastfeed their infants. Blumer I, et al., J Clin Endocrinol Metab 98: , 2013
82 Lactation Oral agents with data on transfer to breastmilk 1. Metformin - <1% 2. Glyburide, Glipizide <1.5% Blumer I, et al., J Clin Endocrinol Metab 98: , 2013 Feig DS, et al., Ann Pharmacother Jul;41(7): Glueck CJ, et al., J Pediatr May;148(5):
83 Preconception During Pregnancy Postpartum Counselling Glycemic control Weight control Co-morbidities Targets SMBG MNT Weight management Pharmacologic Peripartum Lactation
84 Thank you.
Vishwanath Pattan Endocrinology Wyoming Medical Center
Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected
More information2018 Standard of Medical Care Diabetes and Pregnancy
2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy Marjorie Cypress does not have any relevant financial relationships with any commercial interests
More informationGestational Diabetes Mellitus Dr. Fawaz Amin Saad
Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.
More informationDIABETES WITH PREGNANCY
DIABETES WITH PREGNANCY Prof. Aasem Saif MD,MRCP(UK),FRCP (Edinburgh) Maternal and Fetal Risks Diabetes in pregnancy is associated with risks to the woman and to the developing fetus. Maternal and Fetal
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the
More informationManagement of Pregestational and Gestational Diabetes Mellitus
Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is
More informationPrevention and Management of Diabetes in Pregnancy
Prevention and Management of Diabetes in Pregnancy Sridhar Chitturi Consultant Endocrinologist Royal Darwin Hospital Outline of the talk Diabetes in Pregnancy Spectrum Diagnostic criteria Why bother about
More informationDiabetes in Pregnancy
Disclosure Diabetes in Pregnancy I have no conflicts of interest to disclose Jennifer Krupp, MD Maternal Fetal Medicine St. Marys Hospital/SSM Health Madison, WI Objectives Classification of Diabetes Classifications
More informationDiabetes and pregnancy
Diabetes and pregnancy Elisabeth R. Mathiesen Professor, Chief Physician, Dr.sci Specialist in Endocrinology Centre for Pregnant Women with Diabetes Rigshospitalet, University of Copenhagen Denmark Gestational
More informationObjectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy
Objectives Diabetes and Obesity in Pregnancy. Health Impact for the mother and child Bresta Miranda, MD Assistant Professor of Clinical Medicine University of Miami, Miller School of Medicine Review physiologic
More informationDiabetes Related Disclosures
Diabetes Related Disclosures Speakers Bureau Amylin Boehringer Ingelheim Eli Lilly Takeda Classification of Diabetes Diabetes Care January 2011 vol. 34 no. Supplement 1 S11-S61 Type 1 Diabetes Mellitus
More informationCurrent Trends in Diagnosis and Management of Gestational Diabetes
Current Trends in Diagnosis and Management of Gestational Diabetes Shreela Mishra, MD Assistant Clinical Professor UCSF Fresno Medical Education Program 2/2/2019 Disclosures No disclosures 2/2/19 Objectives
More informationDiabetes in pregnancy
Diabetes in pregnancy Bipin Sethi Department of Endocrinology Care Hospitals Hyderabad, India Declared no potential conflict of interest Diabetes in pregnancy Bipin Kumar Sethi Department of Endocrinology,
More informationThe New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program
The New GDM Screening Guidelines Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program Disclosures Current participant (RCH site) for MiTy study Metformin in women
More informationGestational Diabetes. Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network
Gestational Diabetes Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network Outline Definition Prevalence Risk factors complications Diagnosis Management Nonpharmacologic
More informationMaximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE
Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE Heavy Numbers Surgeon General report: 68% of adults in U. S. are overweight or obese
More informationGestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)
Gestational Diabetes in Resouce Limited Area Prof Satyan Rajbhandari (RAJ) Case History RP, 26F Nepali girl settled in the UK Primi Gravida BMI: 23 FH of type 2 DM 75 gm Glucose OGTT in week 25 0 Min
More information2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.
Update on Gestational Diabetes Lorie M. Harper, MD, MSCI Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine 2/18/2018 Disclosure I have no financial conflicts of interest. Objectives
More informationObjectives. Medical Complications of Pregnancy. Potential Conflicts: None. Common Complicating Medical Conditions that Precede Pregnancy
Medical Complications of Potential Conflicts: None Ellen W. Seely, M.D. Director of Clinical Research Endocrine-Hypertension Division Brigham and Women s Hospital Professor of Medicine Harvard Medical
More informationCanadian Journal of Diabetes
Can J Diabetes 42 (2018) S255 S282 Contents lists available at ScienceDirect Canadian Journal of Diabetes journal homepage: www.canadianjournalofdiabetes.com 2018 Clinical Practice Guidelines Diabetes
More informationGestational Diabetes. Gestational Diabetes:
Gestational Diabetes Detection and Management Steven Gabbe, MD The Ohio State University Medical Center Gestational Diabetes: Detection and Management Learning Objectives: At the conclusion of this presentation,
More informationDiabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016
Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016 Medical Director Sweet Success Sutter Medical Center Sacramento Perinatal Associates of Sacramento
More informationDiabetes in Pregnancy
JSAFOG Diabetes in Pregnancy CONTEMPORARY REVIEW ARTICLE Diabetes in Pregnancy Neeta Deshpande Consultant, Diabetologist and Bariatric Physician, Belgaum Diabetes Center, Belgaum, Karnataka, India Correspondence:
More informationPREGESTATIONAL DIABETES (TYPE 1 AND 2)
PREGESTATIONAL DIABETES (TYPE 1 AND 2) Women with diabetes prior to pregnancy need to evaluate and optimize their baseline to assure the healthiest pregnancy possible.[1] The overall prevalence of pregnant
More informationImproving Outcomes in Pregnancies Complicated by Diabetes Mellitus
Improving Outcomes in Pregnancies Complicated by Diabetes Mellitus Steven G. Gabbe, M.D. Emeritus Chief Executive Officer Professor, Obstetrics and Gynecology The Ohio State University Wexner Medical Center
More informationDiabetes in Pregnancy. L.Sekhavat MD
Diabetes in Pregnancy L.Sekhavat MD Diabetes in Pregnancy Gestational Diabetes Pre-gestational diabetes (overt) Insulin dependent (type1) Non-insulin dependent (type 2) Definition Gestational diabetes
More informationPregnancy outcomes in Korean women with diabetes
Pregnancy outcomes in Korean women with diabetes Sung-Hoon Kim Department of Medicine, Cheil General Hospital & Women s Healthcare Center, Dankook University College of Medicine, Seoul, Korea Conflict
More informationDiabetes and Pregnancy
Diabetes and Pregnancy Eric L. Johnson, M.D. Associate Professor Department of Family and Community Medicine University of North Dakota School of Medicine And Health Sciences Assistant Medical Director
More informationCOMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)
COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) Prof. Hayfaa Wahabi, King Saud University, Riyadh Saudi Arabia Hayfaa
More informationPregnancy and Diabetes
Pregnancy and Diabetes Aim(s) and objective(s) This guideline aims to highlight the importance of maintaining good glycaemic control in women of childbearing age contemplating pregnancy, during pregnancy
More informationManagement of Gestational Diabetes
Management of Gestational Diabetes A Diabetes risk assessment should be ascertained at the First prenatal visit. Low Risk: Early blood glucose screening is NOT routinely required if most of the following
More informationGestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014
Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome
More informationManaging Gestational Diabetes. Definition of GDM
Managing Gestational Diabetes Definition of GDM Gestational diabetes is defined as glucose intolerance of variable severity with onset or first recognition during pregnancy that excludes those with overt
More informationScreening and Diagnosis of Diabetes Mellitus in Taiwan
Screening and Diagnosis of Diabetes Mellitus in Taiwan Hung-Yuan Li, MD, MMSc, PhD Attending Physician, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Associate Professor,
More informationDIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor
DIABETES AND PREGNANCY CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor OBJECTIVES Describe targets for blood glucose in pregnancy Discuss the risks to baby if blood glucose
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Susan Drummond RN MSN C-EFM Objectives 1. Describe types of diabetes and diagnosis of gestational diabetes 2. Identify a management plan for diabetes during pregnancy 3. Describe
More informationMANAGEMENT OF DIABETES IN PREGNANCY
MANAGEMENT OF DIABETES IN PREGNANCY Ministry of Health Malaysia Malaysian Endocrine & Metabolic Society Perinatal Society of Malaysia Family Medicine Specialists Association of Malaysia Academy of Medicine
More informationInsulin therapy in gestational diabetes mellitus
Insulin therapy in gestational diabetes mellitus October 15, 2015 Kyung-Soo Kim Division of Endocrinology & Metabolism, Department of Internal Medicine, CHA Bundang Medical Center, CHA University Contents
More informationThe Ever-Changing Approaches to Diabetes in Pregnancy
The Ever-Changing Approaches to Diabetes in Pregnancy Kirsten E. Salmeen, MD Assistant Professor Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine I have nothing to disclose. Approaches
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationA Study of Gestational Diabetes in Patients in a Tertiary Care Hospital in Hyderabad Telangana State, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 10 (2017) pp. 2586-2590 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.610.304
More informationDiabetes in Pregnancy: Detection, Intervention, Prevention. Diabetes in Pregnancy: Outline. Diabetes in Pregnancy
Diabetes in Pregnancy: Detection, Intervention, Prevention Michael Shannon, MD Chair, Providence Endocrinology/Diabetes CAT Diabetes in Pregnancy: Outline Prevalence, Pathophysiology and Complications
More informationSignificant economic burden Conservative because focus on near-term medical costs, omitting increased long-term risks Insulin Resistance
What s New in Gestational Diabetes? Diane Reader RD, CDE International Diabetes Center Park Nicollet Health Services Minneapolis, MN GDM Statistics What s New? Proposed Changes to Diagnostic Criteria Treatment
More informationPregnancies complicated by diabetes. Marina Mickleson Nurse Practitioner Midwife CDE
Pregnancies complicated by diabetes Marina Mickleson Nurse Practitioner Midwife CDE Two types Pre gestational Gestational diabetes Both types are on the increase Pre conception work up is imperative for
More informationCommUnityCare Women s Health Brackenridge Professional Office Building
Guidelines for Diabetes in Pregnancy Effective Date 7/1/11 *This document does not define a standard of care, nor is it intended to dictate an exclusive course of management. There are other accepted strategies
More informationInternational Journal of Diabetes & Metabolic Disorders
Review Article Management of Blood Sugar Degrees in Hyperglycemia in Pregnancy (Hip) Reduces Perinatal, Infant Morbidity & Mortality as a Result of a Large Prospective Cohort Learn From Up, India Rajesh
More informationEffect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome
ORIGINAL ARTICLE Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome ABSTRACT Shagufta Tahir, Shaheen Zafar, Savita Thontia Objective Study design Place & Duration of study Methodology
More informationMETFORMIN A CONVENIENT ALTERNATIVE TO INSULIN FOR INDIAN WOMEN WITH DIABETES IN PREGNANCY
491 METFORMIN A CONVENIENT ALTERNATIVE TO INSULIN FOR INDIAN WOMEN WITH DIABETES IN PREGNANCY ABSTRACT LAVANYA RAI, MEENAKSHI D, ASHA KAMATH 1 OBJECTIVE: To compare the use of metformin with that of insulin
More informationCase study: Individual with type 2 diabetes who is planning a pregnancy
Case study: Individual with type 2 diabetes who is planning a pregnancy Authored by Anne-Marie Felton and Ramon Gomis on behalf of the Global Partnership for Effective Diabetes Management. The Global Partnership
More informationDiabetes & Pregnancy: Management Guide
Diabetes & Pregnancy: Management Guide This program is supported by an educational grant from Novo Nordisk Inc. Inc Diabetes & Pregnancy: Management Guide is supported by an educational grant from Novo
More informationPregestational and Gestational Diabetes
Pregestational and Gestational Diabetes Francis S. Nuthalapaty, MD Greenville Health System University of South Carolina School of Medicine - Greenville Case History 30 year old black female presents to
More informationA S Y N T H E S I Z E D H A N D B O O K ON G E S T A T I O N A L D I A B E T E S
A S Y N T H E S I Z E D H A N D B O O K ON G E S T A T I O N A L D I A B E T E S P R E F A C E Dear reader, This is a synthesized handbook conceived to serve as a tool to health personnel in the screening,
More informationduring pregnancy. any degree of impaired glucose intolerance 11/19/2012 Prevalence & Diagnosis of Gestational Diabetes
Prevalence & Diagnosis of Gestational Diabetes A.Ziaee, MD Endocrinologist Gestational diabetes mellitus (GDM); any degree of impaired glucose intolerance with onset or first recognition during pregnancy.
More informationDisclosures. Diagnosis and Management of Diabetes in Pregnancy. I have nothing to disclose. Type 1. Overview GDMA1
Diagnosis and Management of Diabetes in Pregnancy Kirsten Salmeen, MD Assistant Professor Department of Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine Disclosures I have nothing
More informationDiagnosis and Management of Gestational Diabetes Mellitus. Prof. Dr Md Faizul Islam Chowdhury Professor of Medicine, Department of Medicine, DMCH.
Diagnosis and Management of Gestational Diabetes Mellitus Prof. Dr Md Faizul Islam Chowdhury Professor of Medicine, Department of Medicine, DMCH. Gestational Diabetes Mellitus I, the Fetus I, the fetus
More informationHighlighting the Differences between Preexisting Type 1 and Type 2 Diabetes in Pregnancy and Gestational Diabetes
Highlighting the Differences between Preexisting Type 1 and Type 2 Diabetes in Pregnancy and Gestational Diabetes Elizabeth (Libby) Downs Quiroga, MS, RD, CDE Tandem Diabetes Care Clinical Specialist Grand
More informationAPEC Guidelines Gestational Diabetes Mellitus
Gestational diabetes mellitus (GDM) is defined as insulin resistance of variable severity with onset or first recognition during pregnancy. The prevalence of diabetes mellitus (DM) in the US is growing
More informationStandards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE
Standards of Care in Diabetes 2016-- What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Terminology No longer using the term diabetic. Diabetes does not define people. People
More informationManaging Diabetes Before, During, and After Pregnancy
Managing Diabetes Before, During, and After Pregnancy This program is supported by an educational grant from Novo Nordisk Inc. It has been accredited by AADE for pharmacists, nurses, and dietitians. This
More informationPreexisting and Gestational Diabetes in Pregnancy FLORENCE M BROWN MD SEPTEMBER 8, 2018
Preexisting and Gestational Diabetes in Pregnancy FLORENCE M BROWN MD SEPTEMBER 8, 2018 Objectives 1. Summarize how preconception care and a planned pregnancy reduce maternal and fetal risks. 2. Summarize
More informationPregestational Diabetes in Pregnancy. An Update
Pregestational Diabetes in Pregnancy An Update Disclosures D. Ware Branch, MD Nothing to disclose Questions to Be Addressed What are risks factors for adverse pregnancy outcome in pregestational diabetes?
More informationData from birth certificates in the United
Chapter 36 Pregnancy in Preexisting Diabetes Thomas A. Buchanan, M.D. SUMMARY Data from birth certificates in the United States indicate that maternal diabetes complicates 2%-3% of all pregnancies, but
More informationDiabetes Control In Pregnancy Part I.
Diabetes Control in Pregnancy - Part I Expires Monday, April 30, 2018 Nursing Tamerou Asrat, M.D. Objectives 1. Discuss the different classifications of diabetes and the complications that may be seen
More informationHow to manage a pregnant patient with diabetes
How to manage a pregnant patient with diabetes EASD Postgraduate Course on Clinical Diabetes and its Complications, Shiraz, Iran Rasa Verkauskiene Lithuanian University of Health Sciences 2017 History
More informationSurveillance proposal consultation document
Surveillance proposal consultation document 2018 surveillance of diabetes in pregnancy: management from preconception to the postnatal period (2015) NICE guideline NG3 Surveillance decision We propose
More informationEffect of Gestational Diabetes mellitus Health Education Module on Pregnancy Outcomes
World Journal of Nursing Sciences 1 (3): 76-88, 2015 ISSN 2222-1352 IDOSI Publications, 2015 DOI: 10.5829/idosi.wjns.2015.76.88 Effect of Gestational Diabetes mellitus Health Education Module on Pregnancy
More informationSCREENING FOR DIABETES IN THE FIRST TRIMESTER: WHY & HOW? Jillian Coolen, MD FRCSC DCPNS Spring Conference April 21, 2016
SCREENING FOR DIABETES IN THE FIRST TRIMESTER: WHY & HOW? Jillian Coolen, MD FRCSC DCPNS Spring Conference April 21, 2016 DISCLOSURE Site investigator for the CONCEPTT study funded by Juvenile Diabetes
More informationCounseling and Long-term Follow up After Gestational Disorders
Counseling and Long-term Follow up After Gestational Disorders Tanya Melnik, MD Assistant Professor, University of Minnesota Sarina Martini, MD Ob/Gyn Resident, PGY4 University of Minnesota Counseling
More informationObjectives. Kidney Complications With Diabetes. Case 10/21/2015
Objectives Kidney Complications With Diabetes Brian Boerner, MD Diabetes, Endocrinology, and Metabolism University of Nebraska Medical Center Review screening for, and management of, albuminuria Review
More informationNon-insulin treatment in Type 1 DM Sang Yong Kim
Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay
More informationAre Novel Lifestyle Approaches to Management of Type 2 Diabetes Applicable to Prevention and Treatment of Women with Gestational Diabetes Mellitus?
Open Access Journal Volume: 1.1 Global Diabetes Open Access Journal Are Novel Lifestyle Approaches to Management of Type 2 Diabetes Applicable to Prevention and Treatment of Women with Gestational Diabetes
More informationHAPO Study Rationale. Blinded Participants At Each Field Center
Clinical Implications of IADPSG Recommendations on the Diagnosis & Treatment of Gestational Diabetes Mellitus 36 th Annual Congress The Korean Diabetes Association Busan BEXCO, Korea October 16-17, 2010
More informationFetal & Maternal Outcome of Diabetes Mellitus at Aljomhoria Hospital, Benghazi-Libya, 2010
Fetal & Maternal Outcome of Diabetes Mellitus at Aljomhoria Hospital, Benghazi-Libya, 2010 Najat Bettamer 1, Asma Salem Elakili 2, Farag Ben Ali 1 & Azza SH Greiw 3 1 Gynecology Department, 3 Family &
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Resident School November 5 2014 Goals Be able to screen for gestational and preexisting diabetes Be able to counsel women on the diagnosis of gestational diabetes Understand glucose
More informationReminder: NPIC/QAS CME/CEU Program
V.12.2 Special Report: Perinatal Complications associated with Gestational and Pregestational Diabetes I. Introduction Diabetes mellitus is a metabolic disease characterized by chronic hyperglycemia and
More informationCGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER Case 1: CGM use during pregnancy 29 yo G1P0000 at 10 5/7 weeks gestation presents to set
More informationNeonatal Hypoglycemia. Presented By : Kamlah Olaimat 25\7\2010
Neonatal Hypoglycemia Presented By : Kamlah Olaimat 25\7\2010 Definition The S.T.A.B.L.E. Program defines hypoglycemia as: Glucose delivery or availability is inadequate to meet glucose demand (Karlsen,
More informationDiabetes in obstetric patients
Diabetes in obstetric patients Swedish Society of Obstetric Anaesthesia & Intensive Care Anita Banerjee Obstetric Physician Diabetes & Endocrinology Consultant Outline Scope of the problem Diabetes and
More informationGuideline for Management of Type 2 Diabetes Mellitus: Kingdome of Bahrain Ministry of Health 2016
Guideline for Management of Type 2 Diabetes Mellitus: Kingdome of Bahrain Ministry of Health 2016 1. Screening and diagnosis: Detection type 2 Diabetes are usually based on a two-step approach: Step 1:
More informationGESTATIONAL DIABETES TESTING AND TREAMENT
Boston Medical Center Maternity Care Guideline: GESTATIONAL DIABETES TESTING AND TREAMENT Accepted: August 2015 Updated: December 2018 Contributors: Aviva Lee-Parritz, MD, Sara Alexanian, MD, Kari Radoff,
More informationChanging trends in the management of gestational diabetes mellitus
Changing trends in the management of gestational diabetes mellitus Chandrika N Wijeyaratne Dept of Obsterics & Gynaecology University of Colombo 23. 10. 2016 Mrs SL 36 years G3P1C1 POA 8 weeks FBS = 110
More informationImproving Health Services for Diabetic Pregnant Women who are Attending Governmental Clinics in Nablus and Jenin Districts.
An-Najah National University Faculty of Graduate Studies Improving Health Services for Diabetic Pregnant Women who are Attending Governmental Clinics in Nablus and Jenin Districts. By Lana Ameen Saleem
More informationGestational Diabetes: An Update on Testing. Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN
Gestational Diabetes: An Update on Testing Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN Gestational Diabetes Increased risks of: Still Birth Hydramnios Should Dystocia Prolonged Labor Preeclampsia
More informationComprehensive Diabetes Treatment
Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes
More informationPeripartum and Postpartum Management of Diabetes
Peripartum and Postpartum Management of Diabetes General Principles Glucose goal ~ 100 mg/dl (70-110 mg/dl) Labor is EXERCISE with increased metabolic demands. Insulin requirements decrease however the
More informationEffective Health Care Program
Comparative Effectiveness Review Number 57 Effective Health Care Program Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness Executive Summary Background Diabetes mellitus is
More informationDIABETIC MOTHERS; FREQUENCY OF MACROSOMIA AND HYPOGLYCEMIA IN NEONATES OF (CONTROLLED VERSUS UNCONTROLLED).
The Professional Medical Journal DOI: 10.17957/TPMJ/17.4083 ORIGINAL PROF-4083 DIABETIC MOTHERS; FREQUENCY OF MACROSOMIA AND HYPOGLYCEMIA IN NEONATES OF (CONTROLLED VERSUS UNCONTROLLED). 1. MBBS, FCPS,
More informationPregnancy confers a state of insulin resistance and hyperinsulinemia that. Gestational Diabetes Mellitus MANAGEMENT REVIEW
MANAGEMENT REVIEW Gestational Diabetes Mellitus Amanda Bird Hoffert Gilmartin, Serdar H. Ural, MD, John T. Repke, MD Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Penn State
More informationDiagnosis of gestational diabetes mellitus: comparison between National Diabetes Data Group and Carpenter Coustan criteria
Asian Biomedicine Vol. 8 No. 4 August 2014; 505-509 Brief communication (Original) DOI: 10.5372/1905-7415.0804.320 Diagnosis of gestational diabetes mellitus: comparison between National Diabetes Data
More informationComparative Study between Acarbose and Insulin in the Treatment of GDM.
Original Article DOI: 10.21276/aimdr.2018.4.2.OG5 ISSN (O):2395-2822; ISSN (P):2395-2814 Comparative Study between Acarbose and Insulin in the Treatment of GDM. Minthami Sharon 1, Niloufur Syed Bashutheen
More informationPharmaceutical Care in Gestational Diabetes Mellitus
Review Article Mahidol University Journal of Pharmaceutical Sciences 2013; 40 (4), 50-59 Pharmaceutical Care in Gestational Diabetes Mellitus M. Amin, N. Suksomboon* Department of Pharmacy, Faculty of
More informationHbA1c level in last trimester pregnancy in predicting macrosomia and hypoglycemia in neonate
International Journal of Contemporary Pediatrics Subash S et al. Int J Contemp Pediatr. 2016 Nov;3(4):1334-1338 http://www.ijpediatrics.com pissn 2349-3283 eissn 2349-3291 Original Research Article DOI:
More informationInsulin Therapy Management. Insulin Therapy
Insulin Therapy Management Insulin Therapy Contents Insulin and its effect on glycemic control Physiology of insulin secretion Insulin pharmacokinetics and regimens Insulin dose adjustment for pregnancy
More informationDiabetes and Pregnancy
Diabetes and Pregnancy Dr Warren Gillibrand Deputy Director of Postgraduate Education Department of Nursing & Midwifery Department of AHP and Sports Science w.p.gillibrand@hud.ac.uk Aims of the session
More informationMaternal and Fetal Complications in Diabetes Pregnancy
Maternal and Fetal Complications in Diabetes Pregnancy Helen R Murphy Professor of Medicine (Diabetes & Antenatal Care), UEA Professor of Women s Health, Kings College London hm386@medschl.cam.ac.uk 1
More informationGESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar. Simon Kane March 2016
GESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar Simon Kane March 2016 Objectives History and definitions Definition and Australian data Pathophysiology and prevalence Rationale
More informationADVERSE PREGNANCY OUTCOMES IN GESTATIONAL DIABETES MELLITUS - STUDY IN AN APEX HOSPITAL
ADVERSE PREGNANCY OUTCOMES IN GESTATIONAL DIABETES MELLITUS - STUDY IN AN APEX HOSPITAL *Anuradha Ghosh 1 and Sudip Kumar Saha 2 1 Department of Gynecology and Obstetrics, Sagar Dutta Medical College and
More informationA REVIEW ARTICLE-GESTATIONAL DIABETES MELLITUS
International Journal of Current Pharmaceutical Research ISSN- 0975-7066 Vol 9, Issue 1, 2017 A REVIEW ARTICLE-GESTATIONAL DIABETES MELLITUS Review Article ABSTRACT MUHAS C. *, NASEEF P. P. Department
More informationDiabetes in Pregnancy Dr. Hana
Diabetes in Pregnancy Dr. Hana Introduction Diabetes occurs in 2 5% of all UK pregnancies and its prevalence is rising. Forty years ago the majority of women with diabetes attending an antenatal clinic
More informationOral glucose lowering agents in gestational diabetes. Yes: E. Sobngwi (Cameroon) No: A. Vambergue (France)
Oral glucose lowering agents in gestational diabetes Yes: E. Sobngwi (Cameroon) No: A. Vambergue (France) CONTROVERSIES Oral glucose lowering agents in gestational diabetes «NO» Pr Anne VAMBERGUE Department
More information